Drugs / N02RS1
last change Mar 2016 re-read 3 minutes ago

N02RS1

Developed for
bronchitis
Investigated by
PharmaKing

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02637310 Dec 2015 → Mar 2016 bronchitis PharmaKing Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as N02RS1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02637310 ↗
Route Oral “Three times a day orally” NCT02637310 ↗